1098 related articles for article (PubMed ID: 11376818)
1. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
2. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
Delehaye E; Capobianco S; Bertetto IB; Meloni F
Auris Nasus Larynx; 2008 Jun; 35(2):198-202. PubMed ID: 17869044
[TBL] [Abstract][Full Text] [Related]
3. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
4. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
6. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
7. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
Riga M; Psarommatis I; Korres S; Lyra Ch; Papadeas E; Varvutsi M; Ferekidis E; Apostolopoulos N
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1003-8. PubMed ID: 16359737
[TBL] [Abstract][Full Text] [Related]
8. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
Allen GC; Tiu C; Koike K; Ritchey AK; Kurs-Lasky M; Wax MK
Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
[TBL] [Abstract][Full Text] [Related]
9. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.
McMillan GP; Konrad-Martin D; Dille MF
Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700
[TBL] [Abstract][Full Text] [Related]
11. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
12. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure.
Wooles N; Mulheran M; Bray P; Brewster M; Banerjee AR
J Laryngol Otol; 2015 Dec; 129(12):1174-81. PubMed ID: 26549131
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions.
Ozturan O; Jerger J; Lew H; Lynch GR
Auris Nasus Larynx; 1996; 23():147-51. PubMed ID: 8809338
[TBL] [Abstract][Full Text] [Related]
14. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
[TBL] [Abstract][Full Text] [Related]
15. Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.
Stavroulaki P; Vossinakis IC; Dinopoulou D; Doudounakis S; Adamopoulos G; Apostolopoulos N
Arch Otolaryngol Head Neck Surg; 2002 Feb; 128(2):150-5. PubMed ID: 11843723
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.
Oliveira Bezerra DC; Oliveira de Barcelos R; Carvalho de Castro E; Jardim Duarte CC; de Vasconcellos Carvalhaes Oliveira R; Salgado de Sousa Torraca T; de Araújo-Melo MH; Pereira Bom Braga F; Ramos Ferreira Terceiro B; do Nascimento Brahim Paes LR; de Oliveira Schubach A; Valete-Rosalino CM
PLoS One; 2017; 12(1):e0168492. PubMed ID: 28045920
[TBL] [Abstract][Full Text] [Related]
17. [Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions].
Plinkert PK; Kröber S
Laryngorhinootologie; 1991 Sep; 70(9):457-62. PubMed ID: 1930486
[TBL] [Abstract][Full Text] [Related]
18. Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer.
Yilmaz S; Oktem F; Karaman E
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1041-4. PubMed ID: 19946777
[TBL] [Abstract][Full Text] [Related]
19. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
20. [Hearing evaluation in children during chemotherapy].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Pol Merkur Lekarski; 2005 Sep; 19(111):340-2. PubMed ID: 16358863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]